Evolving concepts of rheumatoid arthritis

[1]  E. Kodama,et al.  Antibodies to 65Kd heat-shock protein were elevated in rheumatoid arthritis , 1994, Clinical Rheumatology.

[2]  D. Chang,et al.  Microsatallite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid Arthritis , 2003, The Journal of Immunology.

[3]  P. Schur,et al.  Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. , 2003, Arthritis and rheumatism.

[4]  L. Joosten,et al.  IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.

[5]  E. Wagner,et al.  HIF-1 mediated upregulation of VEGF and VEGF-R in systemic sclerosis (SSc): Imbalance with angiostatic factors suggests VEGF as a novel option for the treatment of ischemia in patients with SSc , 2002, Annals of the rheumatic diseases.

[6]  Andrea Vondracek,et al.  Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. , 2002, Arthritis and rheumatism.

[7]  C. Benoist,et al.  Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis , 2002, Science.

[8]  R. Fanin,et al.  Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. , 2002, Arthritis and rheumatism.

[9]  A. Wunder,et al.  Synovial mast cells require C5a receptor (CD88) for arthritis induction , 2003, Arthritis Research & Therapy.

[10]  D. Green,et al.  Regional analysis of p53 mutations in rheumatoid arthritis synovium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Maśliński,et al.  High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. , 2002, Arthritis and rheumatism.

[12]  G. Steiner,et al.  Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. , 2002, Arthritis and rheumatism.

[13]  J. Smolen,et al.  Autoantibodies in rheumatoid arthritis and their clinical significance , 2002, Arthritis research.

[14]  S. Barnum,et al.  Local production of complement proteins in rheumatoid arthritis synovium. , 2002, Arthritis and rheumatism.

[15]  M. Karin,et al.  Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. , 2002, Arthritis and rheumatism.

[16]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. , 2002, Arthritis and rheumatism.

[17]  Ralph Weissleder,et al.  Arthritis critically dependent on innate immune system players. , 2002, Immunity.

[18]  G. Firestein,et al.  Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis1 , 2002, The Journal of Immunology.

[19]  Takafumi Yoshida,et al.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. , 2001, The Journal of clinical investigation.

[20]  A R Pettit,et al.  TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. , 2001, The American journal of pathology.

[21]  J. Gebe,et al.  T Cell Selection and Differential Activation on Structurally Related HLA-DR4 Ligands1 , 2001, The Journal of Immunology.

[22]  P. Tak,et al.  Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation , 2001 .

[23]  V. Dixit,et al.  TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice , 2001, Nature Immunology.

[24]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.

[25]  M. Chamorro,et al.  Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. , 2001, Arthritis and rheumatism.

[26]  G. Firestein,et al.  Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. , 2001, Arthritis and rheumatism.

[27]  A. Manning,et al.  NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes1 , 2001, The Journal of Immunology.

[28]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[29]  R N Maini,et al.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.

[30]  Qingbo Xu,et al.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[31]  F. Breedveld,et al.  HLA association with autoimmune disease: a failure to protect? , 2000, Rheumatology.

[32]  L. Joosten,et al.  IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. , 2000, The Journal of clinical investigation.

[33]  F. Breedveld,et al.  Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. , 2000, Arthritis and rheumatism.

[34]  A. Poole,et al.  Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients , 2000, Cell Research.

[35]  T. Tahira,et al.  Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. , 2000, Rheumatology.

[36]  I. McInnes,et al.  A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.

[37]  F. Breedveld,et al.  Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. , 1999, The Journal of rheumatology.

[38]  Josef M. Penninger,et al.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.

[39]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Sumida,et al.  Monoclonal expansion of synoviocytes in rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[41]  R. Pierce,et al.  Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. , 1998, Arthritis and rheumatism.

[42]  F. Breedveld,et al.  Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. , 1998, Clinical immunology and immunopathology.

[43]  P. Miossec,et al.  Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. , 1998, Journal of immunology.

[44]  S. Gay,et al.  Clonally-related Immunoglobulin VH Domains and Nonrandom Use of DH Gene Segments in Rheumatoid Arthritis Synovium , 1998, Molecular medicine.

[45]  F. Medina,et al.  Paleopathology in osseous remains from the 16th century. A survey of rheumatic diseases. , 1998, The Journal of rheumatology.

[46]  D. A. Walsh,et al.  Focally regulated endothelial proliferation and cell death in human synovium. , 1998, The American journal of pathology.

[47]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[48]  T. Rème,et al.  Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue , 1998, Clinical and experimental immunology.

[49]  A. Manning,et al.  AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. , 1998, Autoimmunity.

[50]  D. Green,et al.  Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. Tindall,et al.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.

[52]  A. Boots,et al.  Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[53]  D. Fox,et al.  The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. , 1997, Arthritis and rheumatism.

[54]  K. Tanaka,et al.  Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. , 1997, Journal of Clinical Investigation.

[55]  G. Firestein.  Somatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium , 1997 .

[56]  D E Griswold,et al.  Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. , 1996, The Journal of pharmacology and experimental therapeutics.

[57]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[58]  D. Kirschmann,et al.  Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. , 1995, Journal of immunology.

[59]  J. Goronzy,et al.  HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. , 1995, Human immunology.

[60]  J. Seyer,et al.  Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. , 1995, Autoimmunity.

[61]  F. Emmrich,et al.  Synovial fibroblast-like cells strongly express jun-B and C-fos proto-oncogenes in rheumatoid- and osteoarthritis. , 1995, Scandinavian journal of rheumatology. Supplement.

[62]  J. Woody,et al.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.

[63]  M. Feldmann,et al.  Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[65]  C. Weyand,et al.  The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis , 1992, Annals of Internal Medicine.

[66]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis? , 1990, Arthritis and rheumatism.

[67]  R. Maki,et al.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.

[68]  M. Feldmann,et al.  INHIBITORY EFFECT OF TNFα ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS , 1989, The Lancet.

[69]  J. Roudier,et al.  Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Stage,et al.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.

[71]  B. Rothschild,et al.  Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. , 1988, Science.

[72]  M. Rowley,et al.  Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. , 1986, Arthritis and rheumatism.

[73]  M. Dallman,et al.  Immunisation against heterologous type II collagen induces arthritis in mice , 1980, Nature.

[74]  P. Stastny.  Mixed lymphocyte cultures in rheumatoid arthritis. , 1976, The Journal of clinical investigation.

[75]  S. Ruddy,et al.  ACTIVATION OF THE COMPLEMENT AND PROPERDIN SYSTEMS IN RHEUMATOID ARTHRITIS * , 1975, Annals of the New York Academy of Sciences.

[76]  N. Zvaifler,et al.  The immunopathology of joint inflammation in rheumatoid arthritis. , 1973, Advances in immunology.

[77]  H. Holman,et al.  AN UNUSUAL PROTEIN COMPONENT OF HIGH MOLECULAR WEIGHT IN THE SERUM OF CERTAIN PATIENTS WITH RHEUMATOID ARTHRITIS , 1957, The Journal of experimental medicine.